Selvita S.A. (WSE:SLV)
Poland · Delayed Price · Currency is PLN 16.08
+0.18 (1.13%)
Nov 4, 2026, 3:43 PM CET
Selvita Market Cap
Selvita has a market cap or net worth of 295.16 million as of November 4, 2026. It is the 27,086th most valuable company in the world and the 169th biggest in Poland. Its market cap has decreased by 56.19% in one year.
Market Cap
295.16M
Enterprise Value
450.17M
Revenue
349.00M
Global Rank
Country Rank
#169 Poland
PE Ratio
n/a
ChartMarket Cap Chart
Since October 16, 2019, Selvita's market cap has decreased from 335.40M to 295.16M, a decrease of -12.00%. That is a compound annual growth rate of -1.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 295.16M | -62.78% |
| Dec 30, 2025 | 792.96M | -12.73% |
| Dec 30, 2024 | 908.60M | -15.38% |
| Dec 29, 2023 | 1.07B | -29.43% |
| Dec 30, 2022 | 1.52B | 1.10% |
| Dec 30, 2021 | 1.51B | 66.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.01B |
| NEUCA | 3.17B |
| Synektik Spólka Akcyjna | 2.79B |
| Voxel | 1.62B |
| Scope Fluidics | 458.13M |
| Ryvu Therapeutics | 392.58M |
| Bioceltix | 387.26M |
| Captor Therapeutics Spolka Akcyjna | 336.73M |